336 related articles for article (PubMed ID: 19706115)
1. Successful management of Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using vincristine and ticlopidine.
López V; Martí N; Pereda C; Martín JM; Ramón D; Mayordomo E; Jordá E
Pediatr Dermatol; 2009; 26(3):365-6. PubMed ID: 19706115
[TBL] [Abstract][Full Text] [Related]
2. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment.
Hermans DJ; van Beynum IM; van der Vijver RJ; Kool LJ; de Blaauw I; van der Vleuten CJ
J Pediatr Hematol Oncol; 2011 May; 33(4):e171-3. PubMed ID: 21516018
[TBL] [Abstract][Full Text] [Related]
3. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns.
Garcia-Monaco R; Giachetti A; Peralta O; Napoli N; Lobos P; Gioseffi L; Mariani G
J Vasc Interv Radiol; 2012 Mar; 23(3):417-22. PubMed ID: 22365299
[TBL] [Abstract][Full Text] [Related]
4. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus.
Jahnel J; Lackner H; Reiterer F; Urlesberger B; Urban C
Klin Padiatr; 2012 Oct; 224(6):395-7. PubMed ID: 23070861
[No Abstract] [Full Text] [Related]
5. Vincristine and corticosteroids as first-line treatment of Kasabach-Merritt syndrome in kaposiform hemangioendothelioma.
Drucker AM; Pope E; Mahant S; Weinstein M
J Cutan Med Surg; 2009; 13(3):155-9. PubMed ID: 19426625
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.
Fernandez-Pineda I; Lopez-Gutierrez JC; Chocarro G; Bernabeu-Wittel J; Ramirez-Villar GL
Pediatr Blood Cancer; 2013 Sep; 60(9):1478-81. PubMed ID: 23609996
[TBL] [Abstract][Full Text] [Related]
7. Successful management of a retroperitoneal kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon using alpha-interferon.
Harper L; Michel JL; Enjolras O; Raynaud-Mounet N; Rivière JP; Heigele T; De Napoli-Cocci S
Eur J Pediatr Surg; 2006 Oct; 16(5):369-72. PubMed ID: 17160787
[TBL] [Abstract][Full Text] [Related]
8. Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen.
Hauer J; Graubner U; Konstantopoulos N; Schmidt S; Pfluger T; Schmid I
Pediatr Blood Cancer; 2007 Nov; 49(6):852-4. PubMed ID: 16411198
[TBL] [Abstract][Full Text] [Related]
9. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
Cashell J; Smink GM; Helm K; Xavier F
Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
[TBL] [Abstract][Full Text] [Related]
10. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with vincristine and ticlopidine.
Barabash-Neila R; García-Rodríguez E; Bernabeu-Wittel J; Bueno-Rodríguez I; Ramírez-Villar G; López-Gutierrez JC
Indian J Pediatr; 2012 Oct; 79(10):1386-7. PubMed ID: 22161581
[No Abstract] [Full Text] [Related]
11. Vincristine-ticlopidine-aspirin: an effective therapy in children with Kasabach-Merritt phenomenon associated with vascular tumors.
Fernandez-Pineda I; Lopez-Gutierrez JC; Ramirez G; Marquez C
Pediatr Hematol Oncol; 2010 Nov; 27(8):641-5. PubMed ID: 20863161
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.
Wang Y; Kong L; Sun B; Cui J; Shen W
J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003
[TBL] [Abstract][Full Text] [Related]
13. Kasabach-merritt phenomenon: case series and retrospective review of the mayo clinic experience.
Rodriguez V; Lee A; Witman PM; Anderson PA
J Pediatr Hematol Oncol; 2009 Jul; 31(7):522-6. PubMed ID: 19564750
[TBL] [Abstract][Full Text] [Related]
14. Mediastinal Kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon in an infant: treatment with interferon.
Hartman KR; Moncur JT; Minniti CP; Creamer KM
J Pediatr Hematol Oncol; 2009 Sep; 31(9):690-2. PubMed ID: 19687760
[TBL] [Abstract][Full Text] [Related]
15. [Kasabach-Merritt syndrome on a congenital tufted angioma].
Enjolras O; Wassef M; Dosquet C; Drouet L; Fortier G; Josset P; Merland JJ; Escande JP
Ann Dermatol Venereol; 1998 Apr; 125(4):257-60. PubMed ID: 9747263
[TBL] [Abstract][Full Text] [Related]
16. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up.
Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
Pediatr Blood Cancer; 2015 Apr; 62(4):577-80. PubMed ID: 25346262
[TBL] [Abstract][Full Text] [Related]
17. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon.
Gruman A; Liang MG; Mulliken JB; Fishman SJ; Burrows PE; Kozakewich HP; Blei F; Frieden IJ
J Am Acad Dermatol; 2005 Apr; 52(4):616-22. PubMed ID: 15793511
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma.
Wang H; Guo X; Duan Y; Zheng B; Gao Y
Pediatr Dermatol; 2018 Sep; 35(5):635-638. PubMed ID: 29999213
[TBL] [Abstract][Full Text] [Related]
19. Spindle cell (Kaposiform) hemangioendothelioma with Kasabach-Merritt syndrome in an infant: successful treatment with alpha-2A interferon.
Deb G; Jenkner A; De Sio L; Boldrini R; Bosman C; Standoli N; Donfrancesco A
Med Pediatr Oncol; 1997 May; 28(5):358-61. PubMed ID: 9121401
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of kaposiform hemangioendothelioma and tufted angioma with vincristine.
Fahrtash F; McCahon E; Arbuckle S
J Pediatr Hematol Oncol; 2010 Aug; 32(6):506-10. PubMed ID: 20523249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
